↓ Skip to main content

MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells

Overview of attention for article published in BMC Complementary Medicine and Therapies, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
16 Mendeley
Title
MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells
Published in
BMC Complementary Medicine and Therapies, November 2013
DOI 10.1186/1472-6882-13-325
Pubmed ID
Authors

Xiao-feng Zhai, Fan-fu Fang, Qun Liu, Yong-bin Meng, Yu-yu Guo, Zhe Chen

Abstract

Bufalin is a major active compound of cinobufacini, which comes from dried toad venom and has been used for treatments of various cancers in China for many years. A number of studies have demonstrated that bufalin can induce apoptosis in some cancers. However, effects and mechanism of bufalin on prostate cancer cells remain unknown.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 25%
Student > Master 3 19%
Student > Postgraduate 2 13%
Researcher 2 13%
Student > Ph. D. Student 1 6%
Other 2 13%
Unknown 2 13%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 25%
Agricultural and Biological Sciences 3 19%
Medicine and Dentistry 3 19%
Pharmacology, Toxicology and Pharmaceutical Science 2 13%
Computer Science 1 6%
Other 0 0%
Unknown 3 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2013.
All research outputs
#4,159,569
of 22,731,677 outputs
Outputs from BMC Complementary Medicine and Therapies
#788
of 3,621 outputs
Outputs of similar age
#48,934
of 301,922 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#23
of 82 outputs
Altmetric has tracked 22,731,677 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,621 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 301,922 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.